EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacologic Modulation of the PAR-2–ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells

Layla Amiri iD, Rajashree Patnaik iD, Riah Lee Varghese iD, Bintul Huda iD, Yajnavalka Banerjee iD

International Journal of Molecular Sciences · 16.01.2026 · 27 (2) · 916

DOI: 10.3390/ijms27020916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.01.2026. Verfasst von Layla Amiri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, …. Hauptthemen laut MEDLINE: Apoptosis, Colorectal Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Receptor, PAR-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mohammed Bin Rashid University of Medicine and Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation constitutes a well-established driver of colorectal carcinogenesis, yet the molecular circuitry linking inflammatory receptor signalling to tumour cell survival remains incompletely delineated. Here we demonstrate that the HMG-CoA reductase inhibitors atorvastatin and rosuvastatin modulate inflammatory survival pathways in colorectal cancer cells in a manner consistent with targeted interference with the protease-activated receptor 2 (PAR-2)–extracellular signal-regulated kinase (ERK)–tumour necrosis factor-α (TNF-α) signalling axis. Using lipopolysaccharide-stimulated HT-29 and Caco-2 cells as complementary models of inflammatory colorectal malignancy, we show that both statins selectively attenuate PAR-2 expression at the protein and transcript levels while leaving structurally related PAR-1 unaffected. This pattern of receptor modulation is accompanied by suppression of total ERK1/2 expression, ERK1/2 phosphorylation, and the transcriptional target DUSP6, together with attenuation of TNF-α secretion. Importantly, these signaling shifts are associated with dual apoptotic programs; the extrinsic pathway, reflected by transcriptional upregulation and proteolytic activation of caspase-8; and the intrinsic mitochondrial pathway, evidenced by reciprocal modulation of Bcl-2 family proteins favoring Bax over Bcl-2. Both pathways converge upon activation of executioner caspase-3 and an increase in Annexin V-defined apoptotic fractions, indicating re-engagement of programmed cell death under inflammatory stress. Notably, rosuvastatin consistently demonstrates superior potency across signaling endpoints, achieving comparable biological effects at lower concentrations than atorvastatin. Collectively, these data indicate that clinically deployed statins target the PAR-2–ERK axis and are associated with re-activation of apoptotic pathways in inflammatory colorectal cancer models, while leaving open the possibility that additional statin-responsive networks contribute to their pro-apoptotic effects. This mechanistic framework provides biological plausibility for epidemiologic observations linking statin use with reduced colorectal cancer risk and improved outcomes, and supports further translational evaluation of PAR-2-directed statin strategies in colorectal malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisColorectal NeoplasmsHydroxymethylglutaryl-CoA Reductase InhibitorsReceptor, PAR-2InflammationMAP Kinase Signaling SystemHumansTumor Necrosis Factor-alphaAtorvastatinCaco-2 CellsHT29 CellsSignal TransductionRosuvastatin CalciumCell Survival

Stichwörter der Autor:innen

ERK signallingPAR-2TNF-αapoptosisatorvastatincaspase activationcolorectal cancerinflammationrosuvastatinstatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsReceptor, PAR-2Tumor Necrosis Factor-alphaAtorvastatinRosuvastatin Calcium

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Al Razi St, Umm Hurair 2, Dubai Healthcare City, Dubai 505055, United Arab Emirate…

ORCID-Profile: Layla Amiri, Rajashree Patnaik, Riah Lee Varghese, Bintul Huda, Yajnavalka Banerjee

Förderung

  • Mohammed Bin Rashid University of Medicine and Health Sciences

Zitieren

APA

Amiri, L., Patnaik, R., Varghese, R. L., Huda, B., & Banerjee, Y. (2026). Pharmacologic Modulation of the PAR-2–ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells. International Journal of Molecular Sciences, 27(2), 916. https://doi.org/10.3390/ijms27020916

Vancouver

Amiri L, Patnaik R, Varghese RL, Huda B, Banerjee Y. Pharmacologic Modulation of the PAR-2–ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells. International Journal of Molecular Sciences. 2026;27(2):916. doi:10.3390/ijms27020916

BibTeX
@article{Amiri2026,
  author = {Amiri, Layla and Patnaik, Rajashree and Varghese, Riah Lee and Huda, Bintul and Banerjee, Yajnavalka},
  title = {Pharmacologic Modulation of the PAR-2–ERK Axis by Statins Converts Inflammatory Survival Signalling into Apoptosis in Colorectal Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {2},
  pages = {916},
  doi = {10.3390/ijms27020916}
}
Kostenlos starten →